BECLOVENT Drug Patent Profile
✉ Email this page to a colleague
When do Beclovent patents expire, and what generic alternatives are available?
Beclovent is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in BECLOVENT is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BECLOVENT?
- What are the global sales for BECLOVENT?
- What is Average Wholesale Price for BECLOVENT?
Summary for BECLOVENT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BECLOVENT at DailyMed |
![BECLOVENT drug patent expirations Drug patent expirations by year for BECLOVENT](/p/graph/s/t/BECLOVENT-patent-expirations.png)
Recent Clinical Trials for BECLOVENT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fred Hutchinson Cancer Research Center | Phase 2 |
Mount Sinai Hospital, Canada | N/A |
Sunnybrook Health Sciences Centre | N/A |
US Patents and Regulatory Information for BECLOVENT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | BECLOVENT | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 018153-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BECLOVENT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | BECLOVENT | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 018153-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | BECLOVENT | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 018153-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BECLOVENT
See the table below for patents covering BECLOVENT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 348115 | ⤷ Sign Up | |
Norway | 140303 | ⤷ Sign Up | |
Australia | 5466073 | ⤷ Sign Up | |
Austria | A352973 | ⤷ Sign Up | |
South Africa | 7302713 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |